Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Davis

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 14, 2020
Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR CorrectionShingo Suzuki, Ana M Crane, Varada Anirudhan, et al.
Annals of the American Thoracic Society|June 11, 2026
Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical TrialRachel W Linnemann, George M Solomon, Adrianna L Westbrook, et al.
Stem Cell Reports|July 12, 2016
Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional DefectsTamara J Laskowski, Yasmine Van Caeneghem, Rasoul Pourebrahim, et al.
Plos One|February 14, 2025
Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocolColin E Swenson, William R Hunt, Candela Manfredi, et al.
The Lancet. Respiratory Medicine|August 29, 2024
Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTR<sup>N1303K</sup> in the USA: a prospective, multicentre, open-label, single-arm trialGeorge M Solomon, Rachel W Linnemann, Rachel Rich, et al.
The Journal of Clinical Investigation|May 3, 2017
Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cellsFinn Hawkins, Philipp Kramer, Anjali Jacob, et al.
Stem Cell Reports|March 17, 2015
Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cellsAna M Crane, Philipp Kramer, Jacquelin H Bui, et al.
Surgical Endoscopy|November 1, 2023
The Laparoscopy in Biliary Exploration Research and Training Initiative (LIBERTI) trial: simulator-based training for laparoscopic management of choledocholithiasisVanessa N VanDruff, B Fernando Santos, Kristine Kuchta, et al.
Stem Cell Reports|November 10, 2015
Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem CellsZita Garate, Oscar Quintana-Bustamante, Ana M Crane, et al.
Cell Stem Cell|October 25, 2020
Derivation of Airway Basal Stem Cells from Human Pluripotent Stem CellsFinn J Hawkins, Shingo Suzuki, Mary Lou Beermann, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 14, 2020
Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR CorrectionShingo Suzuki, Ana M Crane, Varada Anirudhan, et al.
Annals of the American Thoracic Society|June 11, 2026
Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical TrialRachel W Linnemann, George M Solomon, Adrianna L Westbrook, et al.
Stem Cell Reports|July 12, 2016
Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional DefectsTamara J Laskowski, Yasmine Van Caeneghem, Rasoul Pourebrahim, et al.
Plos One|February 14, 2025
Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocolColin E Swenson, William R Hunt, Candela Manfredi, et al.
The Lancet. Respiratory Medicine|August 29, 2024
Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTR<sup>N1303K</sup> in the USA: a prospective, multicentre, open-label, single-arm trialGeorge M Solomon, Rachel W Linnemann, Rachel Rich, et al.
The Journal of Clinical Investigation|May 3, 2017
Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cellsFinn Hawkins, Philipp Kramer, Anjali Jacob, et al.
Stem Cell Reports|March 17, 2015
Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cellsAna M Crane, Philipp Kramer, Jacquelin H Bui, et al.
Surgical Endoscopy|November 1, 2023
The Laparoscopy in Biliary Exploration Research and Training Initiative (LIBERTI) trial: simulator-based training for laparoscopic management of choledocholithiasisVanessa N VanDruff, B Fernando Santos, Kristine Kuchta, et al.
Stem Cell Reports|November 10, 2015
Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem CellsZita Garate, Oscar Quintana-Bustamante, Ana M Crane, et al.
Cell Stem Cell|October 25, 2020
Derivation of Airway Basal Stem Cells from Human Pluripotent Stem CellsFinn J Hawkins, Shingo Suzuki, Mary Lou Beermann, et al.
Pageof 7